Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL169164 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL26376399 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL4793246 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL2525609 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL10865193 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL6521877 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL148759 | 1.00 | — | — | |
| SCHEMBL5784769 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL14917740 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL3950984 | 1.00 | PAOX (0.59) | PAOXGPR84FFAR1FFAR4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792241-B1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO PERFUMERY CO LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-11407703-B2 | Method for converting hydroxyl group of alcohol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-08-09 | — | — | US | disclosed |
| EP-3792241-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | Takasago International Corporation (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
| WO-2019216355-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | 高砂香料工業株式会社 (JP) | 2019-11-14 | — | — | WO | disclosed |
| EP-2337809-B1 | POLYCARBONATE POLYOL COMPOSITIONS AND METHODS | NOVOMER INC (US) | 2017-08-02 | — | — | EP | disclosed |
| US-20150025279-A1 | PROCESS FOR PRODUCING DODECANE-1,12-DIOL BY REDUCTION OF LAURYL LACTONE PRODUCED FROM THE OXIDATION OF CYCLODODECANONE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2015-01-22 | — | — | US | disclosed |
| US-20070191606-A1 | 2,2-Bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-08-16 | — | — | US | disclosed |
| EP-1818336-A1 | 2,2-bis-(4-hydroxyphenyl)-alkyl onium salt and a process for the preparation thereof | Council of Scientific and Industrial Research (IN) | 2007-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191606-A1 | 2,2-Bis(4-hydroxyphenyl)-alkyl onium salt and process for the preparation thereof | HACL2, HAO2, HPD | PAOX 204/4885GPR84 3936/4885FFAR1 1996/4885 |
| US-20150025279-A1 | PROCESS FOR PRODUCING DODECANE-1,12-DIOL BY REDUCTION OF LAURYL LACTONE PRODUCED FROM THE OXIDATION OF CYCLODODECANONE | DECR1, CYP51A1, DECR2 | PAOX 323/4885GPR84 1658/4885FFAR1 765/4885 |
| US-11407703-B2 | Method for converting hydroxyl group of alcohol | ADH1C, CBR1, NAP1L4 | PAOX 1480/4885GPR84 1804/4885FFAR1 1443/4885 |
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | ADH1C, CBR1, NAP1L4 | PAOX 1480/4885GPR84 1804/4885FFAR1 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.